Htg Molecular Diagnostics Inc (HTGM) Inventory Turnover Ratio, from first quarter 2023 to first quarter 2022, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Htg Molecular Diagnostics Inc  (NASDAQ: HTGM)
 

Htg Molecular Diagnostics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Htg Molecular Diagnostics Inc inventory turnover ratio, the Htg Molecular Diagnostics Inc's ability to sell and replace its inventory in the first quarter 2023, sequentially increased to 3.74 in the first quarter 2023, HTGM's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Htg Molecular Diagnostics Inc in Mar 31 2023 quarter, has decreased to 98 days, compare to 131 days, in the Dec 31 2022 quarter.

Within Healthcare sector 108 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2023, to 790, from total ranking in the fourth quarter 2022 at 1211.

HTGM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Htg Molecular Diagnostics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HTGM Inventory Turnover Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Inventory Growth -67.62 % -54.25 % -27.79 % -15.63 % 26.18 %
Y / Y Cost of Sales Growth 34.45 % 49.95 % -31.81 % 4.47 % 8.9 %
Inventory Turnover Ratio (TTM) 3.74 2.78 2.04 2.03 1.92
HTGM's Total Ranking # 790 # 1211 # 1530 # 1062 # 1582
Average inventory processing period 98 131 179 180 190
Seq. Inventory Growth -27.98 % -46.2 % -13.58 % -3.29 % 1.75 %
Seq. Cost of Sales Growth -43.42 % 202.86 % -33.87 % 18.64 % -36.9 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 3
Healthcare Sector # 109
Overall Market # 790

Inventory Turnover Ratio Statistics
High Average Low
7.42 3.42 1.42
(Dec 31 2019)   (Mar 31 2016)



HTGM Company Profile >> Back to HTGM Efficiency Comparisons >> Compare HTGM Inventory Turnover Ratio to its Competitors

Financial Statements
Htg Molecular Diagnostics Inc's Inventories $ 1 Millions Visit HTGM's Balance sheet
Htg Molecular Diagnostics Inc's Cost of Revenues TTM $ 5 Millions Visit HTGM's Income Statement
What are HTGM's Sales? Visit HTGM's Sales by Segment

Other Inventory Turnover Ratios
Htg Molecular Diagnostics Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HTGM's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HTGM's Competitors
Inventory Turnover Ratio for HTGM's Suppliers
Inventory Turnover Ratio for HTGM's Customers

You may also want to know
HTGM's Sales Growth Rates HTGM's Pe Price to earnings ratio HTGM's Receivables Turnover Ratio HTGM's Stock Quote
HTGM's Net Income Growth Rates HTGM's Ps Price to Sales ratio HTGM's Sales per Employee HTGM's Asset Turnover Ratio
HTGM's Net Margin HTGM's Pb Price to Book ratio HTGM's Financial Strength Ratios HTGM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2023 Inventories at quarter ending Mar 31 2023
Vaso Corporation  20.23 $ 31.806  Millions$ 2  Millions
Rvl Pharmaceuticals Plc  17.91 $ 9.611  Millions$ 1  Millions
Viemed Healthcare Inc   17.53 $ 57.192  Millions$ 3  Millions
Vanda Pharmaceuticals Inc   17.37 $ 23.391  Millions$ 1  Millions
Eton Pharmaceuticals Inc   16.30 $ 8.173  Millions$ 1  Millions
Biocept Inc   15.08 $ 21.133  Millions$ 1  Millions
Aspira Women s Health inc   14.89 $ 4.054  Millions$ 0  Millions
23andme Holding Co  13.90 $ 164.993  Millions$ 12  Millions
Lantheus Holdings Inc   13.59 $ 497.256  Millions$ 37  Millions
Teladoc Health Inc   13.48 $ 747.069  Millions$ 55  Millions
Natera Inc   13.47 $ 495.127  Millions$ 37  Millions
Option Care Health Inc   13.38 $ 3,149.812  Millions$ 235  Millions
Wearable Health Solutions, Inc.  12.78 $ 0.466  Millions$ 0  Millions
Invitae Corporation  12.73 $ 408.582  Millions$ 32  Millions
Rockwell Medical inc   12.40 $ 66.973  Millions$ 5  Millions
Sunlink Health Systems Inc   11.45 $ 20.581  Millions$ 2  Millions
Precipio inc   11.30 $ 7.226  Millions$ 1  Millions
Puma Biotechnology Inc   11.19 $ 57.467  Millions$ 5  Millions
Sotera Health Company  11.15 $ 447.891  Millions$ 40  Millions
Myriad Genetics Inc   11.09 $ 213.200  Millions$ 19  Millions
Qhslab Inc   10.77 $ 0.622  Millions$ 0  Millions
Infusystem Holdings Inc  10.05 $ 50.777  Millions$ 5  Millions
Cryo cell International Inc   9.88 $ 8.757  Millions$ 1  Millions
Prophase Labs Inc   9.47 $ 41.922  Millions$ 4  Millions
Castle Biosciences Inc   9.25 $ 36.247  Millions$ 4  Millions
Dermtech Inc   9.19 $ 14.138  Millions$ 2  Millions
Semler Scientific inc   9.03 $ 4.551  Millions$ 1  Millions
Novavax inc   9.00 $ 921.521  Millions$ 102  Millions
Irhythm Holdings Inc   8.90 $ 134.425  Millions$ 15  Millions
Agile Therapeutics Inc  8.65 $ 16.612  Millions$ 2  Millions

Date modified: 2026-08-29T17:30:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.